safety of compounded tirzepatide first-new analyses B12-compounded @EliLillyandCo https://t.co/Dl3jAe9l8h Eli Lilly just issued a

This once-weekly medication, approved for type 2 diabetes and chronic weight management, has a five-day half-life that provides some scheduling flexibility

First responders performed water rescues Tuesday night into Wednesday, Lewis County Commissioner Agnes Quinn Queen said

P.KnippG.LukacovaV.et al (2015)

Definition of health care provider NCI Dictionary of Cancer Terms (n.d.)

Nicholls, MBBS, PhD, director of the Monash Victorian Heart Institute and professor of cardiology at Monash University in Melbourne, Australia, and colleagues randomly assigned 13,165 participants with type 2 diabetes and atherosclerotic cardiovascular disease (ASCVD) to a maximum tolerated dose of 5 mg, 10 mg or 15 mg once-weekly subcutaneous tirzepatide (Mounjaro, Eli Lilly) or 1.5 mg of once-weekly subcutaneous dulaglutide (Trulicity, Eli Lilly) with sham dose escalation

She continues to struggle with health issues, including ongoing blood clots that require extended use of blood thinners